Publications by authors named "Yuk Ying Pang"

Claim this Profile
R
Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumors.
Shiv K Sethi, Claire E Bradley, Lukas Bialkowski, Yuk Ying Pang, Cynthia D Thompson

NPJ Vaccines· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques.
Alberto Peretti, Diana G Scorpio, Wing-Pui Kong, Yuk-Ying S Pang, Michael P McCarthy

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of several thousand highly diverse circular DNA viruses.
Michael J Tisza, Diana V Pastrana, Nicole L Welch, Brittany Stewart, Alberto Peretti, Yuk-Ying S Pang

Elife· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
Patricia M Day, Andrea S Weisberg, Cynthia D Thompson, Michelle M Hughes, Yuk Ying Pang

J Virol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8 Memory T Cells.
Nicolas Çuburu, Rina Kim, Geoffrey C Guittard, Cynthia D Thompson, Patricia M Day, Yuk-Ying S Pang

J Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
Lukai Zhai, Julianne Peabody, Yuk-Ying Susana Pang, John Schiller, Bryce Chackerian

Antiviral Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.
Carla Cerqueira, Cynthia D Thompson, Patricia M Day, Yuk-Ying S Pang, Douglas R Lowy

Mol Ther Methods Clin Dev· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Rhonda C Kines, Vladimir Zarnitsyn, Teresa R Johnson, Yuk-Ying S Pang, Kizzmekia S Corbett

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
Carla Cerqueira, Yuk-Ying S Pang, Patricia M Day, Cynthia D Thompson, Christopher B Buck

J Virol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of Nucleophosmin (NPM1/B23) in Assembly of Infectious HPV16 Capsids.
Patricia M Day, Cynthia D Thompson, Yuk Ying Pang, Douglas R Lowy, John T Schiller

Papillomavirus Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
Nicolas Çuburu, Kening Wang, Kyle N Goodman, Yuk Ying Pang, Cynthia D Thompson

J Virol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.
Alessandra Handisurya, Patricia M Day, Cynthia D Thompson, Christopher B Buck, Yuk-Ying S Pang

J Virol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.
Nicolas Çuburu, Barney S Graham, Christopher B Buck, Rhonda C Kines, Yuk-Ying S Pang

J Clin Invest· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
Patricia M Day, Yuk-Ying S Pang, Rhonda C Kines, Cynthia D Thompson, Douglas R Lowy

Clin Vaccine Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.
N Hanumantha Rao, P Baji Babu, L Rajendra, R Sriraman, Yuk-Ying S Pang

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.
Nicolas Cuburu, Mi-Na Kweon, Catherine Hervouet, Hye-Ran Cha, Yuk-Ying S Pang

J Immunol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.
Patricia M Day, Cynthia D Thompson, Christopher B Buck, Yuk-Ying S Pang, Douglas R Lowy

J Virol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.
Jiahua Qian, Yujun Dong, Yuk-Ying S Pang, Ramy Ibrahim, Jay A Berzofsky

Int J Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Diana V Pastrana, Ratish Gambhira, Christopher B Buck, Yuk-Ying S Pang, Cynthia D Thompson

Virology· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maturation of papillomavirus capsids.
Christopher B Buck, Cynthia D Thompson, Yuk-Ying S Pang, Douglas R Lowy, John T Schiller

J Virol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Diana V Pastrana, Christopher B Buck, Yuk-Ying S Pang, Cynthia D Thompson, Philip E Castle

Virology· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.
Yevgeniy Y Studentsov, Mark Schiffman, Howard D Strickler, Gloria Y F Ho, Yuk-Ying Susana Pang

J Clin Microbiol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis